State-of-the-art document on optimal contemporary management of cardiomyopathies

Data de publicação: Data Ahead of Print:

Autores da FMUP

  • Brenda Eugénia Carvalho De Moura Cardoso

    Autor

Participantes de fora da FMUP

  • Seferovic, PM
  • Polovina, M
  • Rosano, G
  • Bozkurt, B
  • Metra, M
  • Heymans, S
  • Mullens, W
  • Bauersachs, J
  • Sliwa, K
  • de Boer, RA
  • Farmakis, D
  • Thum, T
  • Olivotto, I
  • Rapezzi, C
  • Linhart, A
  • Corrado, D
  • Tschöpe, C
  • Milinkovic, I
  • Genis, AB
  • Filippatos, G
  • Keren, A
  • Asanin, M
  • Krljanac, G
  • Maksimovic, R
  • Skouri, H
  • Ben Gal, T
  • Volterrani, M
  • Abdelhamid, M
  • Lopatin, Y
  • Chioncel, O
  • Coats, AJS

Unidades de investigação

Abstract

Cardiomyopathies represent significant contributors to cardiovascular morbidity and mortality. Over the past decades, a progress has occurred in characterization of the genetic background and major pathophysiological mechanisms, which has been incorporated into a more nuanced diagnostic approach and risk stratification. Furthermore, medications targeting core disease processes and/or their downstream adverse effects have been introduced for several cardiomyopathies. Combined with standard care and prevention of sudden cardiac death, these novel and emerging targeted therapies offer a possibility of improving the outcomes in several cardiomyopathies. Therefore, the aim of this document is to summarize practical approaches to the treatment of cardiomyopathies, which includes the evidence-based novel therapeutic concepts and established principles of care, tailored to the individual patient aetiology and clinical presentation of the cardiomyopathy. The scope of the document encompasses contemporary treatment of dilated, hypertrophic, restrictive and arrhythmogenic cardiomyopathy. It was based on an expert consensus reached at the Heart Failure Association online Workshop, held on 18 March 2021.

Dados da publicação

ISSN/ISSNe:
1388-9842, 1879-0844

European Journal of Heart Failure  Wiley-Blackwell

Tipo:
Review
Páginas:
1899-1922

Citações Recebidas na Web of Science: 3

Documentos

  • Não há documentos

Métricas

Filiações mostrar / ocultar

Keywords

  • Aetiology; Arrhythmogenic cardiomyopathy; Dilated cardiomyopathy; Hypertrophic cardiomyopathy; Management; Mortality; Restrictive cardiomyopathy; Treatment

Proyectos asociados

Loop diuretic suspension in Chronic Heart Failure patients - a retrospective study

Investigador Principal: Brenda Eugénia Carvalho de Moura Cardoso

Estudo Clínico Académico (Loop diuretic) . 2023

Citar a publicação

Partilhar a publicação